Expertise in
5
conditions

Dr. Eben L. Rosenthal

General Surgery
Office
1720 2nd Ave S, 
Birmingham, AL 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
5
conditions
Office
1720 2nd Ave S, 
Birmingham, AL 

Overview

Eben Rosenthal is a General Surgeon practicing medicine in Birmingham, Alabama.

Dr. Rosenthal is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Oral Cancer, Arterial Insufficiency, Necrosis, Laryngectomy, and Glossectomy.

He is actively involved in clinical research, co-authoring 268 peer reviewed articles and participating in 10 clinical trials. Dr. Rosenthal is currently accepting new patients.

Specialties

General Surgery

Licenses

Otolaryngology in AL

Hospital Affiliations

Vanderbilt University Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Alliant Health
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 3 Less Insurance Carriers -

Locations

Office
1720 2nd Ave S, Birmingham, AL 35294

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase I/II Study Evaluating the Safety and Pharmacokinetics of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Pancreas Cancer During Surgical Procedures
A Phase I/II Study Evaluating the Safety and Pharmacokinetics of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Pancreas Cancer During Surgical Procedures
Enrollment Status: Recruiting
Publish Date: March 17, 2026
Intervention Type: Biological, Drug, Procedure
Study Drugs: Panitumumab, Panitumumab-IRDye800
Study Phase: Phase 1/Phase 2
Pilot Evaluating 111In-Panitumumab for Nodal Staging in Head and Neck Cancer
Pilot Evaluating 111In-Panitumumab for Nodal Staging in Head and Neck Cancer
Enrollment Status: Suspended
Publish Date: December 24, 2025
Intervention Type: Drug, Procedure
Study Drug: 111I-n Panitumumab
Study Phase: Phase 1
Pilot Study of 89Zr Panitumumab in Pancreas Cancer
Pilot Study of 89Zr Panitumumab in Pancreas Cancer
Enrollment Status: Withdrawn
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Zr-89 Panitumumab
Study Phase: Phase 1
Pilot Study Evaluating Panitumumab-IRDye800 and 89Zr-Panitumumab for Dual-Modality Imaging for Nodal Staging in Head and Neck Cancer
Pilot Study Evaluating Panitumumab-IRDye800 and 89Zr-Panitumumab for Dual-Modality Imaging for Nodal Staging in Head and Neck Cancer
Enrollment Status: Completed
Publish Date: May 19, 2023
Intervention Type: Device, Drug
Study Drugs: Panitumumab-IRDye800, Zirconium Zr-89 Panitumumab
Study Phase: Phase 1
A Phase II Study Evaluating Panitumumab-IRDye800 vs. Sentinel Node Biopsy and (Selective) Neck Dissection for Metastatic Lymph Node Identification in Patients With Head and Neck Cancer
A Phase II Study Evaluating Panitumumab-IRDye800 vs. Sentinel Node Biopsy and (Selective) Neck Dissection for Metastatic Lymph Node Identification in Patients With Head and Neck Cancer
Enrollment Status: Completed
Publish Date: November 10, 2022
Intervention Type: Drug
Study Phase: Phase 2
Phase I, Open-label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Head and Neck Cancer During Surgical Procedures
Phase I, Open-label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Head and Neck Cancer During Surgical Procedures
Enrollment Status: Completed
Publish Date: September 24, 2021
Intervention Type: Drug, Device
Study Phase: Phase 1
Open-Label Study Evaluating Cetuximab-IRDye800 as an Optical Imaging Agent to Detect Neoplasms During Neurosurgical Procedures
Open-Label Study Evaluating Cetuximab-IRDye800 as an Optical Imaging Agent to Detect Neoplasms During Neurosurgical Procedures
Enrollment Status: Terminated
Publish Date: March 31, 2020
Intervention Type: Procedure, Biological, Drug
Study Phase: Phase 1/Phase 2
Phase I, Open-label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Cetuximab-IRDye800 as an Optical Imaging Agent to Detect Cancer During Surgical Procedures
Phase I, Open-label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Cetuximab-IRDye800 as an Optical Imaging Agent to Detect Cancer During Surgical Procedures
Enrollment Status: Terminated
Publish Date: June 24, 2019
Intervention Type: Drug
Study Phase: Phase 1
View 7 Less Clinical Trials

268 Total Publications

Response to: "Letter to Editor Following 'Visualization of Scattered Tumor Regression Following Neoadjuvant Chemoimmunotherapy With a Novel Intraoperative PET/CT Scanner'".
Response to: "Letter to Editor Following 'Visualization of Scattered Tumor Regression Following Neoadjuvant Chemoimmunotherapy With a Novel Intraoperative PET/CT Scanner'".
Journal: Head & neck
Published: July 14, 2026
Similar Doctors
Expertise in
47
conditions
Dr. John D. Christein
General Surgery
Expertise in
47
conditions
Dr. John D. Christein
General Surgery
Referral may be required

Office

500 Office Park Dr, 
Mountain Brk, AL 
 (2.9 miles away)
205-592-5077
Languages Spoken:
English
See accepted insurances
Accepting New Patients

John Christein is a General Surgeon practicing medicine in Mountain Brk, Alabama. Dr. Christein is highly rated in 47 conditions, according to our data. His clinical expertise encompasses Ampullary Cancer, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Christein is currently accepting new patients.

Expertise in
15
conditions
Dr. Benjamin J. Pearce
General Surgery
Expertise in
15
conditions
Dr. Benjamin J. Pearce
General Surgery
Referral may be required

University Of Alabama Health Services Foundation PC

2000 6th Ave S, 
Birmingham, AL 
 (0.4 miles away)
205-934-2003
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Benjamin Pearce is a General Surgeon practicing medicine in Birmingham, Alabama. Dr. Pearce is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Thoracic Aortic Aneurysm, Abdominal Aortic Aneurysm (AAA), Peripheral Artery Disease, Carotid Artery Surgery, and Aneurysm Repair. Dr. Pearce is currently accepting new patients.

Expertise in
7
conditions
Dr. Jayme E. Locke
General Surgery
Expertise in
7
conditions
Dr. Jayme E. Locke
General Surgery
Referral may be required

UAB Hospital Birmingham

619 19th St S, 
Birmingham, AL 
 (0.4 miles away)
205-975-9200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jayme Locke is a General Surgeon practicing medicine in Birmingham, Alabama. Dr. Locke is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses End-Stage Renal Disease (ESRD), Obesity, Liver Failure, Kidney Transplant, and Liver Transplant. Dr. Locke is currently accepting new patients.

Frequently Asked Questions about Dr. Eben L. Rosenthal

How do I make an appointment with Dr. Eben L. Rosenthal?

You can book an appointment with Dr. Eben L. Rosenthal by calling their office at 205-934-9713. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Eben L. Rosenthal a top-rated expert for Laryngectomy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Eben L. Rosenthal is classified as an Elite expert for Laryngectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Eben L. Rosenthal specialize in?

While Dr. Eben L. Rosenthal is a General Surgery, they have specific expertise in Laryngectomy, Glossectomy, and Oral Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within General Surgery.

Does Dr. Eben L. Rosenthal participate in research or clinical trials?

Yes. Dr. Eben L. Rosenthal has published 268 articles and abstracts on conditions like Laryngectomy. You can view a list of Dr. Eben L. Rosenthal's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Eben L. Rosenthal accept my insurance?

Dr. Eben L. Rosenthal accepts most major insurance plans, including Alliant Health and Anthem BCBS. We recommend calling the office directly at 205-934-9713 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rosenthal's expertise for a condition
ConditionClose
View All 12 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile